Extraintestinal manifestations and complications in inflammatory bowel disease: from shared genetics to shared biological pathways - PubMed
Review
Extraintestinal manifestations and complications in inflammatory bowel disease: from shared genetics to shared biological pathways
Suzanne van Sommeren et al. Inflamm Bowel Dis. 2014 Jun.
Abstract
Background: The clinical presentation of the inflammatory bowel diseases (IBD) is extremely heterogenous and is characterized by various extraintestinal manifestations and complications (EIM). Increasing genetic insight for IBD and EIM shows multiple shared susceptibility loci. We hypothesize that, next to these overlapping genetic risk loci, distinct disease pathways are shared between IBD and EIM.
Methods: The overlapping genetic risk loci for IBD and its EIM were searched in literature. We assessed shared disease pathways by performing an extensive pathway analysis by protein-protein interaction and cotranscriptional analysis, using both publicly available and newly developed databases.
Results: Reliable genetic data were available for primary sclerosing cholangitis, ankylosing spondylitis, decreased bone mineral density, colorectal carcinoma, gallstones, kidney stones, and deep venous thrombosis. We found an extensive overlap in genetic risk loci, especially for IBD and primary sclerosing cholangitis and ankylosing spondylitis. We identified 370 protein-protein interactions, of which 108 are statistically specific. We identified 446 statistically specific cotranscribed gene pairs. The interactions are shown to cluster in specific biological pathways.
Conclusions: We show that the pathogenetic overlap between IBD and its EIM extends beyond shared risk genes to distinctive shared biological pathways. We define genetic background as a risk factor for IBD-EIM alongside known mechanisms such as malabsorption and medication. Clustering patients based on distinctive pathways may enable stratification of patients to predict development of EIM.
Similar articles
-
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.
Khrom M, Long M, Dube S, Robbins L, Botwin GJ, Yang S, Mengesha E, Li D, Naito T, Bonthala NN, Ha C, Melmed G, Rabizadeh S, Syal G, Vasiliauskas E, Ziring D, Brant SR, Cho J, Duerr RH, Rioux J, Schumm P, Silverberg M, Ananthakrishnan AN, Faubion WA, Jabri B, Lira SA, Newberry RD, Sandler RS, Xavier RJ, Kugathasan S, Hercules D, Targan SR, Sartor RB, Haritunians T, McGovern DPB. Khrom M, et al. Gastroenterology. 2024 Jul;167(2):315-332. doi: 10.1053/j.gastro.2024.02.026. Epub 2024 Mar 13. Gastroenterology. 2024. PMID: 38490347
-
Greuter T, Vavricka SR. Greuter T, et al. Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):307-317. doi: 10.1080/17474124.2019.1574569. Epub 2019 Feb 20. Expert Rev Gastroenterol Hepatol. 2019. PMID: 30791773 Review.
-
Treatment of extraintestinal manifestations in inflammatory bowel disease.
Lakatos PL, Lakatos L, Kiss LS, Peyrin-Biroulet L, Schoepfer A, Vavricka S. Lakatos PL, et al. Digestion. 2012;86 Suppl 1:28-35. doi: 10.1159/000341950. Epub 2012 Oct 5. Digestion. 2012. PMID: 23051724 Review.
-
Brophy S, Pavy S, Lewis P, Taylor G, Bradbury L, Robertson D, Lovell C, Calin A. Brophy S, et al. J Rheumatol. 2001 Dec;28(12):2667-73. J Rheumatol. 2001. PMID: 11764216
-
Biologics for extraintestinal manifestations of IBD.
Vavricka SR, Scharl M, Gubler M, Rogler G. Vavricka SR, et al. Curr Drug Targets. 2014;15(11):1064-73. doi: 10.2174/1389450115666140908125453. Curr Drug Targets. 2014. PMID: 25198785 Review.
Cited by
-
Insights into renal and urological complications of inflammatory bowel disease.
Singh A, Khanna T, Mahendru D, Kahlon J, Kumar V, Sohal A, Yang J. Singh A, et al. World J Nephrol. 2024 Sep 25;13(3):96574. doi: 10.5527/wjn.v13.i3.96574. World J Nephrol. 2024. PMID: 39351187 Free PMC article. Review.
-
Urolithiasis in inflammatory bowel disease and bariatric surgery.
Gkentzis A, Kimuli M, Cartledge J, Traxer O, Biyani CS. Gkentzis A, et al. World J Nephrol. 2016 Nov 6;5(6):538-546. doi: 10.5527/wjn.v5.i6.538. World J Nephrol. 2016. PMID: 27872836 Free PMC article.
-
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.
Khrom M, Long M, Dube S, Robbins L, Botwin GJ, Yang S, Mengesha E, Li D, Naito T, Bonthala NN, Ha C, Melmed G, Rabizadeh S, Syal G, Vasiliauskas E, Ziring D, Brant SR, Cho J, Duerr RH, Rioux J, Schumm P, Silverberg M, Ananthakrishnan AN, Faubion WA, Jabri B, Lira SA, Newberry RD, Sandler RS, Xavier RJ, Kugathasan S, Hercules D, Targan SR, Sartor RB, Haritunians T, McGovern DPB. Khrom M, et al. Gastroenterology. 2024 Jul;167(2):315-332. doi: 10.1053/j.gastro.2024.02.026. Epub 2024 Mar 13. Gastroenterology. 2024. PMID: 38490347
-
Validity, Reliability, and Responsiveness of the Brief Pain Inventory in Inflammatory Bowel Disease.
Jelsness-Jørgensen LP, Moum B, Grimstad T, Jahnsen J, Opheim R, Prytz Berset I, Hovde Ø, Torp R, Frigstad SO, Huppertz-Hauss G, Bernklev T. Jelsness-Jørgensen LP, et al. Can J Gastroenterol Hepatol. 2016;2016:5624261. doi: 10.1155/2016/5624261. Epub 2016 Jun 19. Can J Gastroenterol Hepatol. 2016. PMID: 27446848 Free PMC article.
-
Olivera PA, Zuily S, Kotze PG, Regnault V, Al Awadhi S, Bossuyt P, Gearry RB, Ghosh S, Kobayashi T, Lacolley P, Louis E, Magro F, Ng SC, Papa A, Raine T, Teixeira FV, Rubin DT, Danese S, Peyrin-Biroulet L. Olivera PA, et al. Nat Rev Gastroenterol Hepatol. 2021 Dec;18(12):857-873. doi: 10.1038/s41575-021-00492-8. Epub 2021 Aug 27. Nat Rev Gastroenterol Hepatol. 2021. PMID: 34453143 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials